{"disease":{"id":"lipodystrophy","name":"lipodystrophy"},"drugs":{"marketed":[{"drug_id":"tesamorelin","indication_name":"Reduction of excess abdominal fat in HIV lipodystrophy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"TESAMORELIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"metreleptin","indication_name":"Acquired generalized lipodystrophy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Myalept","generic_name":"METRELEPTIN","company_name":"Amylin Pharms Llc","drug_phase":"marketed","molecular_target":"Leptin receptor","drug_class":"Leptin Analog [EPC]","quality_score":10,"revenue":null,"mechanism":"Myalept works by mimicking the action of leptin, a hormone that regulates fat distribution and metabolism."},{"drug_id":"metreleptin","indication_name":"Acquired partial lipodystrophy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Myalept","generic_name":"METRELEPTIN","company_name":"Amylin Pharms Llc","drug_phase":"marketed","molecular_target":"Leptin receptor","drug_class":"Leptin Analog [EPC]","quality_score":10,"revenue":null,"mechanism":"Myalept works by mimicking the action of leptin, a hormone that regulates fat distribution and metabolism."},{"drug_id":"metreleptin","indication_name":"Congenital generalized lipodystrophy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Myalept","generic_name":"METRELEPTIN","company_name":"Amylin Pharms Llc","drug_phase":"marketed","molecular_target":"Leptin receptor","drug_class":"Leptin Analog [EPC]","quality_score":10,"revenue":null,"mechanism":"Myalept works by mimicking the action of leptin, a hormone that regulates fat distribution and metabolism."},{"drug_id":"tesamorelin-acetate","indication_name":"Lipodystrophy due to Human immunodeficiency virus infection and antiretroviral therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Egrifta","generic_name":"TESAMORELIN ACETATE","company_name":"Theratechnologies","drug_phase":"marketed","molecular_target":"Growth hormone-releasing hormone receptor","drug_class":"Growth Hormone Releasing Factor Analog","quality_score":10,"revenue":null,"mechanism":"Egrifta works by mimicking the action of growth hormone-releasing hormone to stimulate the release of growth hormone."}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00001219","title":"Comparing Magnetic Resonance Imaging/Spectroscopy Techniques","phase":"","overall_status":"TERMINATED","enrollment_count":49946,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":false},{"nct_id":"NCT00082628","title":"Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":326,"lead_sponsor_name":"EMD Serono","has_results":true},{"nct_id":"NCT05383456","title":"The Visceral Adiposity Measurement and Observation Study","phase":"","overall_status":"COMPLETED","enrollment_count":196,"lead_sponsor_name":"Theratechnologies","has_results":false},{"nct_id":"NCT03039491","title":"Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT05424913","title":"Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's Lipodystrophy","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Réunion","has_results":false},{"nct_id":"NCT04903847","title":"Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":126,"lead_sponsor_name":"Thomas Benfield","has_results":false},{"nct_id":"NCT07090629","title":"The Benefits of the Measureof Epicardial Adipose Tissue During Coronary Calcium Assessment of the Refine Cardiovascular Risk Assessment at Reunion Island.","phase":"","overall_status":"COMPLETED","enrollment_count":126,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Réunion","has_results":false},{"nct_id":"NCT04887675","title":"Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"University of Novi Sad","has_results":false},{"nct_id":"NCT06089759","title":"Performance and Safety of the Lipo-transfer Cannulas in Patients Underlying Lipofilling Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Aesthetic Group","has_results":false},{"nct_id":"NCT07313787","title":"Effects of Meal Macronutrients on Postprandial Lipids","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT02325674","title":"MEASuRE: Metreleptin Effectiveness And Safety Registry","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Amryt Pharma","has_results":false},{"nct_id":"NCT06236932","title":"Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, \"SIDERALE\"","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Federico II University","has_results":false},{"nct_id":"NCT05419037","title":"Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT03283475","title":"Different Surgical Modalities for Thigh Lipodystrophy Including Liposuction,Thigh Lift and Liposuction Assisted Thigh Lift","phase":"NA","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT04904406","title":"Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"Thomas Benfield","has_results":false},{"nct_id":"NCT06107439","title":"Impact of Lipodystrophy on the Inflammatory State of Non-diabetic Dunnigan Reunion Island Subjects","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Réunion","has_results":false},{"nct_id":"NCT04578379","title":"Insulin Regulated Amino Peptidase in Patients With Familial Lipodystrophy of DUNNIGAN","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Réunion","has_results":false},{"nct_id":"NCT05164341","title":"Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":69,"lead_sponsor_name":"Amryt Pharma","has_results":false},{"nct_id":"NCT03407313","title":"CONFORM: Rotational Fractional Resection for Submental Contouring","phase":"NA","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Recros Medica, Inc.","has_results":true},{"nct_id":"NCT05789251","title":"Assess the Possibility of Diagnosing Diabetes and Rediabetes Following Oral Induced Hyperglycemia in Patients With Dunnigan's Partial Familial Lipodystrophy by Replacing 75 g of Glucose With a Standardized Carbohydrate Breakfast and Continuous Interstitial Monitoring Glucose)","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Réunion","has_results":false},{"nct_id":"NCT05402982","title":"Intraoperative Fluid Management of Liposuction , Cardiometry Versus Rohrich Formula","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Ahmed Abdel Wahed Ali","has_results":false},{"nct_id":"NCT05930106","title":"Carotid Doppler Peak Velocity Variation in Liposuction Fluid Management","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"TJ Plast Advanced Center for Plastic Surgery","has_results":false},{"nct_id":"NCT05239156","title":"Evaluating the Performance and Safety of the Medical Device Janesse in the Treatment of Facial Dermal Tissue Defects","phase":"NA","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"I.R.A. Istituto Ricerche Applicate S.p.A.","has_results":false},{"nct_id":"NCT05239130","title":"Evaluating the Performance and Safety of the Medical Device Auralya® in the Treatment of Facial Dermal Tissue Defects","phase":"NA","overall_status":"UNKNOWN","enrollment_count":48,"lead_sponsor_name":"I.R.A. Istituto Ricerche Applicate S.p.A.","has_results":false},{"nct_id":"NCT05239351","title":"Evaluating Performance and Safety of the Medical Device Jalucomplex in the Treatment of Facial and Neck Tissue Defects","phase":"NA","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"I.R.A. Istituto Ricerche Applicate S.p.A.","has_results":false},{"nct_id":"NCT05239117","title":"Evaluating the Performance and Safety of the Medical Device Plenhyage® in the Treatment of Dermal Tissue Defects","phase":"NA","overall_status":"UNKNOWN","enrollment_count":48,"lead_sponsor_name":"I.R.A. Istituto Ricerche Applicate S.p.A.","has_results":false},{"nct_id":"NCT03986983","title":"Shockwave Therapy (SWT)","phase":"NA","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Escola Superior de Tecnologia da Saúde do Porto","has_results":false},{"nct_id":"NCT02492997","title":"Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference","phase":"NA","overall_status":"TERMINATED","enrollment_count":44,"lead_sponsor_name":"Venus Concept","has_results":true},{"nct_id":"NCT02527343","title":"The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":40,"lead_sponsor_name":"Akcea Therapeutics","has_results":true},{"nct_id":"NCT03275259","title":"Shock Waves for Treatment of Gynoid Lipodystrophy and Localized Fat","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Indústria Brasileira Equipamentos Médicos - IBRAMED","has_results":false},{"nct_id":"NCT02262806","title":"Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":29,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT07220785","title":"Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":28,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT05470504","title":"Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT04845165","title":"Study of Cortisol Metabolism in Familial Partial Lipodystrophy Type 2","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT01778556","title":"Short-term Effects of Leptin in People With Lipodystrophy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":true},{"nct_id":"NCT02262832","title":"Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":24,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT03826160","title":"Growth Hormone Dynamics and Cardiac Steatosis in HIV","phase":"","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT01679197","title":"Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"University of Michigan","has_results":true},{"nct_id":"NCT04656054","title":"Hemoglobin Level, Coagulopathy Profile and Electrolyte Balance","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Alaa Hassan M. Elhawary","has_results":false},{"nct_id":"NCT05088460","title":"A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":20,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT03445351","title":"Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS","phase":"NA","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"JULIANY DE SOUZA ARAUJO","has_results":false},{"nct_id":"NCT04159415","title":"Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT06502990","title":"Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Amryt Pharma","has_results":false},{"nct_id":"NCT05996536","title":"Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)","phase":"","overall_status":"RECRUITING","enrollment_count":14,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT02654977","title":"CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"University of Michigan","has_results":true},{"nct_id":"NCT04026178","title":"Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Aegerion Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03936829","title":"Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT04340388","title":"Contribution of Dolutegravir to Obesity and Cardiovascular Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Augusta University","has_results":false},{"nct_id":"NCT04517253","title":"A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT06548100","title":"A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}